Holen Sie sich die Stockscreener-App
75.42
2.15%
1.59
Handel nachbörslich:
75.40
-0.02
-0.03%
Schlusskurs vom Vortag:
$73.83
Offen:
$74.51
24-Stunden-Volumen:
436.73K
Relative Volume:
0.51
Marktkapitalisierung:
$4.14B
Einnahmen:
$1.39B
Nettoeinkommen (Verlust:
$-242.49M
KGV:
-16.85
EPS:
-4.4759
Netto-Cashflow:
$173.29M
1W Leistung:
+3.43%
1M Leistung:
+17.48%
6M Leistung:
+18.14%
1J Leistung:
+80.09%
1-Tages-Spanne:
$70.74
$75.81
1-Wochen-Bereich:
$70.74
$75.81
52-Wochen-Spanne:
$41.02
$75.81
Livanova Plc Stock (LIVN) Company Profile
Firmenname
Livanova Plc
Sektor
Branche
Telefon
4402033250662
Adresse
20 EASTBOURNE TERRACE, LONDON
Compare LIVN vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
75.42 | 4.06B | 1.39B | -242.49M | 173.29M | -4.4759 |
ABT
Abbott Laboratories
|
86.67 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
313.00 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.60 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.64 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.54 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-19 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2025-10-01 | Herabstufung | Goldman | Buy → Neutral |
| 2025-05-20 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | Bestätigt | Needham | Buy |
| 2024-02-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-04-14 | Eingeleitet | Mizuho | Neutral |
| 2022-12-21 | Eingeleitet | Barclays | Equal Weight |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-02-24 | Hochstufung | UBS | Neutral → Buy |
| 2021-12-03 | Eingeleitet | Goldman | Buy |
| 2021-08-20 | Bestätigt | Needham | Buy |
| 2021-07-20 | Hochstufung | Needham | Hold → Buy |
| 2021-03-03 | Herabstufung | Berenberg | Buy → Hold |
| 2021-01-05 | Herabstufung | Needham | Buy → Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-06-26 | Bestätigt | Needham | Buy |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-02-28 | Bestätigt | Needham | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-08 | Eingeleitet | Stifel | Buy |
| 2018-05-31 | Bestätigt | Needham | Buy |
| 2018-02-28 | Bestätigt | Needham | Buy |
Alle ansehen
Livanova Plc Aktie (LIVN) Neueste Nachrichten
LivaNova appoints Stefano Folli to lead its cardiopulmonary business unit - MSN
LivaNova names Stefano Folli as president, CP - Medical Buyer
Why (LIVN) Price Action Is Critical for Tactical Trading - Stock Traders Daily
LIVN Technical Analysis & Stock Price Forecast - Intellectia AI
Paradice Investment Management LLC's LivaNova PLC(LIVN) Holding History - GuruFocus
LivaNova names Stefano Folli as cardiopulmonary president - Investing.com UK
LivaNova appoints Franco Poletti as President, Cardiopulmonary - TipRanks
LivaNova names Stefano Folli as cardiopulmonary president By Investing.com - Investing.com South Africa
LivaNova names Stefano Folli to head cardiopulmonary unit - StreetInsider
LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit - Business Wire
LivaNova PLC stock (US5356991077): cardiac device specialist in focus after regulatory update and ea - AD HOC NEWS
LivaNova’s SWOT analysis: medical device stock eyes growth plan By Investing.com - Investing.com Canada
LivaNova’s SWOT analysis: medical device stock eyes growth plan - Investing.com
LivaNova PLC Lifts 2026 Outlook After Strong Q1 - TipRanks
LivaNova stock hits 52-week high at 73.31 USD By Investing.com - Investing.com Australia
LivaNova stock hits 52-week high at 73.31 USD - Investing.com India
LivaNova to present at Goldman Sachs Global Healthcare Conference in June - MSN
LivaNova to Present at Goldman Sachs Global Healthcare Conference in June 2026 - BioSpace
LivaNova to Present at Goldman Sachs Global Healthcare Conference in June - Business Wire
Will LivaNova's (LIVN) Return to Quarterly Profitability Reset Investor Expectations on Its Turnaround Narrative? - simplywall.st
LivaNova PLC stock (US5356991077): cardiac device maker updates investors after latest earnings - AD HOC NEWS
Total debt per share of LivaNova Plc – SWB:LIA - TradingView
LivaNova PLCOrdinary Shares (NQ: LIVN - FinancialContent
Vagus Nerve Stimulators Market to Reach USD 1.86 Billion by 2033 - openPR.com
ETFs Investing in LivaNova Plc Stocks - TradingView
LivaNova stock (US5356991077): Medical device leader with Nasdaq listing - AD HOC NEWS
Understanding Momentum Shifts in (LIVN) - Stock Traders Daily
LivaNova (LIVN) Q3 2025 Earnings Transcript - AOL.com
LivaNova (LIVN) Stock Forum and Discussion - Moomoo
Drug Resistant Epilepsy Market to Reach US$ 1.28 Billion by 2033 - openPR.com
LivaNova stock hits 52-week high at 71.97 USD By Investing.com - Investing.com Nigeria
LivaNova PLC Lifts Guidance After Strong Q1 Call - TipRanks
LivaNova (LIVN) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Why LivaNova (LIVN) Is Up 18.0% After Boosting 2026 Outlook And Winning Aura6000 FDA Approval - Yahoo Finance
LivaNova stock hits 52-week high at 71.97 USD - Investing.com India
LivaNova PLC 2026 Q1ResultsEarnings Call Presentation (NASDAQ:LIVN) 2026-05-08 - Seeking Alpha
LivaNova PLC (LIVN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Active Implantable Medical Devices Market Size is Anticipated - openPR.com
LIVN Maintained by Baird -- Price Target Lowered to $76.00 - GuruFocus
LIVN Maintained by Mizuho -- Price Target Raised to $90.00 - GuruFocus
LivaNova (LIVN) Q1 2025 Earnings Transcript - AOL.com
Q1 2026 LivaNova PLC Earnings Call Transcript - GuruFocus
LivaNova PLC (NASDAQ:LIVN) Q1 2026 Earnings Call Transcript - Insider Monkey
LivaNova Q1 2026 slides: double-digit growth drives guidance raise By Investing.com - Investing.com Australia
LivaNova revenue up 14.3% to USD 362.3M in Q1 2026 - Medical Buyer
LivaNova: Q1 Earnings Snapshot - theheraldreview.com
Finanzdaten der Livanova Plc-Aktie (LIVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Livanova Plc-Aktie (LIVN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Poletti Franco | President, Cardiopulmonary |
Mar 30 '26 |
Option Exercise |
0.00 |
3,184 |
0 |
12,125 |
| Shvartsburg Alex | Chief Financial Officer |
Mar 30 '26 |
Option Exercise |
0.00 |
30,835 |
0 |
57,515 |
| Makatsaria Vladimir | Chief Executive Officer |
Mar 30 '26 |
Option Exercise |
0.00 |
21,042 |
0 |
25,326 |
| Bolton Stephanie | President, Global Epilepsy |
Mar 30 '26 |
Option Exercise |
0.00 |
17,815 |
0 |
30,566 |
| Kozmina Natalia | Chief Human Resources Officer |
Mar 30 '26 |
Option Exercise |
0.00 |
6,389 |
0 |
6,389 |
| Poletti Franco | President, Cardiopulmonary |
Mar 11 '26 |
Option Exercise |
57.60 |
2,140 |
123,264 |
10,990 |
| Poletti Franco | President, Cardiopulmonary |
Dec 15 '25 |
Option Exercise |
0.00 |
967 |
0 |
9,266 |
| PODLOGAR SUSAN M | Director |
Dec 15 '25 |
Option Exercise |
0.00 |
2,355 |
0 |
2,355 |
| Hutchinson Michael Damon | SVP, CLO and Company Secretary |
Dec 15 '25 |
Option Exercise |
0.00 |
2,254 |
0 |
7,920 |
| Story Brooke | Director |
Nov 18 '25 |
Sale |
53.94 |
250 |
13,485 |
6,232 |
1.27%
2.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):